Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.
| Conditions: | Ovarian|Melanoma|Renal|Prostate|Colorectal|Endometrial Carcinoma|Cervical Carcinoma|Testicular Cancer|Thyroid Cancer|Small Cell Lung Carcinoma|Mesothelioma|Breast Carcinoma|Esophageal Carcinoma|Gastric Cancer|Pancreatic Carcinoma|Neuroendocrine Cancer|Liv |
| Start Date: | February 1, 2007 |
| Phase: | Phase I |
| Status: | Completed |
| NCT ID: | NCT00423254 |
| Study Type: | Interventional |
| Intervention: | Biological: PSMA/PRAME|Biological: PSMA/PRAME |
| Study Design: | Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Mannkind Corporation |
| Ages: | Adult|Senior |
| Enrollment: | 12 |
| Funded By: | Industry |
| First Received: | January 12, 2007 |
| End Date: | November 1, 2009 |
| Last Updated: | August 2, 2010 |
| Last Verified: | August 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
